Listing on the Nigerian Stock Exchange (NGX) provides companies with numerous benefits, including increased visibility, access to capital, and enhanced credibility.
However, not all companies choose to list due to regulatory requirements, the cost of compliance, and the need for transparency in financial reporting.
For those that do, market capitalization becomes a crucial indicator of their financial health and investor confidence.
In 2024, health companies listed on the NGX demonstrated their financial robustness through their market capitalizations.
This metric, which reflects the total market value of a company’s outstanding shares, provides insights into the company’s size, stability, and market presence.
Methodology
Nairametrics ranked the top health companies based on their market capitalization as of the end of July 2024, using the daily summary of the last day in July 2024, exploring their operations, histories, and positions in the market.
Market Capitalization: N36,200,000,000
Mecure Industries Plc, established in 1990, is the largest pharmaceutical and healthcare company on the NGX by market capitalization.
The company specializes in the manufacturing and distribution of a broad range of healthcare products, including pharmaceuticals, diagnostics, and medical devices.
Headquartered in Lagos, Mecure Industries has a significant market presence with distribution channels throughout Nigeria and beyond.
The company says that it is dedicated to quality and innovation which has positioned it as a leader in the healthcare sector.
As of July 31 2024, Mecure Industries’ market capitalization was N36,200,000,000, with shares priced at N9.05.
